Controlled release osmotic drug delivery systems for oral applications

Transport Processes in Pharmaceutical Systems

Volumn , Issue , 1999, Pages 411-444

  Cardinal, John R ^a,b  

^a Oakmont Pharmaceuticals   (United States)

^b Applied Analytical Industries Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056041650     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203909478     Document Type: Chapter

References (66)

1. JR Robinson, VHL Lee, eds. Controlled Drug Delivery, Fundamentals and Applications. New York: Marcel Dekker, 1987.
2. A Kydonius, ed. Treatise on Controlled Drug Delivery. New York: Marcel Dekker, 1992.
3. JR Cardinal, L Witchey-Lakshmann. Drug delivery in veterinary medicine. In: A Kydonius, ed. Treatise on Controlled Drug Delivery. New York: Marcel Dekker, 1992, pp 465-490.
4. M Rathbone, ed. Veterinary drug delivery. Part I. Adv Drug Delivery Rev 28:301-392, 1997.
5. G Santus, RW Baker. Osmotic drug delivery: A review of the patent literature. J Controlled Release 35:1-21, 1995.
6. O Kedem, A Katchalsky. Thermodynamic analysis of the permeability of biological membranes to nonelectrolytes. Biochim Biophys Acta 27:229-246, 1958.
7. BZ Ginsburg, A Katchalsky. The frictional coefficients of the flows of non-electrolytes through artificial membranes. J Gen Physiol 47:403-420, 1963.
8. SZ Song, JR Cardinal, SJ Wisniewski, SW Kim. Mechanisms of solute permeation through hydrogel films: An irreversible thermodynamic approach. Abstracts of Papers Presented at the 126th National Meeting of the American Pharmaceutical Association, 1979.
9. BK Fritzinger, SK Bauman, DJ Lyman. Membrane characteristics, permeability parameters, and frictional coefficients for cupraphane. J Biomed Mater Res 5:3-16, 1971.
10. F Theeuwes. Elementary osmotic pump. J Pharm Sci 64:1987-1991, 1975.
11. S Rose, JF Nelson. A continuous long-term injector. Aust J Exp Biol 33:415-420, 1955.
12. GP Polli, CE Shoop, WM Grim. Controlled release medicinal tablets. US Patent 3,538,214, 1970.
13. T Higuchi, HM Leeper. Osmotic dispenser. US Patent 3,732,865, 1973.
14. T Higuchi, HM Leeper. Improved osmotic dispenser employing magnesium sulfate and magnesium chloride. US Patent 3,760,804, 1973.
15. T Higuchi. Osmotic dispenser with collapsible supply container. US Patent 3,760,805, 1973.
16. GM Zentner, GS Rork, KJ Himmelstein. Osmotic flow through controlled porosity films: An approach to the delivery of water soluble compounds. In: JM Anderson, SW Kim, eds. Advances in Drug Delivery Systems. New York: Elsevier, 1986, pp 217-230.
17. KA Kelly. Motility of the stomach and gastroduodenal junction. In: LR Johnson, ed. Physiology of the Gastrointestinal Tract. New York: Raven Press, 1981, pp 393-410.
18. A Katchalsky, PF Curran. Nonequilibrium Thermodynamics in Biophysics. Cambridge, MA: Harvard University Press, 1965.
19. RA Robinson, RH Stokes. Electrolyte Solutions, 2nd ed (revised). London: Butterworths, 1970.
20. SM Herbig, JR Cardinal, RW Korsmeyer, KL Smith. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Controlled Release 35:127-136, 1995.
21. F Theeuwes, AD Ayer. Laminated osmotic system for dispensing beneficial agent. US Patent 4,014,334, 1976.
22. F Theeuwes, D Swanson, P Wong, P Bonson, V Place, K Heimlich, KC Kwan. Elementary osmotic pump for indomethacin. J Pharm Sci 72:253-258, 1983.
23. AG Thombre, GM Zentner, KJ Himmelstein. Mechanism of water transport in controlled porosity osmotic devices. J Membrane Sci 40:279-310, 1989.
24. GA McClelland, SC Sutton, K Engle, GM Zentner. The solubility-modulated osmotic pump: In vitro/in vivo release of diltiazem hydrochloride. Pharm Res 8:88-92, 1991.
25. GA McClelland, RJ Stubbs, JA Fix, SA Pogany, GM Zentner. Pharm Res 8:873-876, 1991.
26. GM Zentner, GA McClelland, SC Sutton. Controlled porosity solubility-and resinmodulated osmotic delivery systems for release of diltiazem hydrochloride. J Controlled Release 16:237-244, 1991.
27. JR Cardinal, SM Herbig, RW Korsmeyer, J Lo, KL Smith, AG Thombre. The use of asymmetric membranes in delivery devices. EPO 0357369, 1990.
28. JR Cardinal, SM Herbig, RW Korsmeyer, J Lo, KL Smith, AG Thombre. Asymmetric membranes in delivery devices. US Patent 5,698,220, 1997.
29. RW Korsmeyer, KD Wilner, WE Ballinger, FC Falkner. Asymmetric membrane tablets for delivery of glipizide. Proceedings of the International Symposium on the Controlled Release of Bioactive Materials, Stockholm, 1997, pp 239-240.
30. RW Korsmeyer, SM Herbig, KL Smith, JR Cardinal, AC Curtiss, MB Fergione, RA Wilson. Single-step process for coating multiparticulates with asymmetric membranes. Proceedings of the International Symposium on the Controlled Release of Bioactive Materials, Stockholm, 1997, pp 531-532.
31. AG Thombre, JR Cardinal, AR DeNoto, SM Herbig, KL Smith. Asymmetric membrane capsules for osmotic drug delivery. I. Development of manufacturing process. J Controlled Release 57:55-64, 1999.
32. AG Thombre, JR Cardinal, AR DeNoto, DC Gibbes. Asymmetric membrane capsules for osmotic drug delivery. II. In vitro and in vivo performance. J Controlled Release 57:65-73, 1999.
33. SC Sutton, K Engle, RA Deeken, KE Plute, RD Shaffer. Performance of diltiazem tablet and multiparticulate osmotic formulations in the dog. Pharm Res 7:874-878, 1990.
34. PR Magruder, B Barclay, PSL Wong, F Theeuwes. Composition comprising salbutomal. US Patent 4,751,071, 1988.
35. F Theeuwes. Osmotic device having microporous reservoir. US Patent 3,977,404, 1977.
36. F Theeuwes. Osmotic dispenser with gas generating means. US Patent 4,036,228, 1977.
37. D Swanson, D Edgren. Osmotic device that improves delivery properties in situ. US Patent 4,326,525, 1982.
38. P Bonson, PSL Wong, F Theeuwes. Method of delivering drug with aid of effervescent activity generated in the environment of use. US Patent 4,344,929, 1982.
39. AD Ayer, PSL Wong. Dosage form comprising solubility regulating member. US Patent 4,755,180, 1988.
40. S Khanna. Therapeutic system for sparing soluble active ingredients. US Patent 4,992,278, 1991.
41. F Theeuwes. Osmotic system for delivery of selected beneficial agents having varying degrees of solubility. US Patent 4,111,201, 1978.
42. F Theeuwes. Osmotic system for the controlled delivery of agent over time. US Patent 4,111,202, 1978.
43. F Theeuwes. Osmotic system with means for improving delivery kinetics of system. US Patent 4,111,203, 1978.
44. F Theeuwes. System with microporous releasing diffusor. US Patent 4,309,996, 1982.
45. R Cortese, F Theeuwes. Osmotic device with hydrogel driving member. US Patent 4,327,725, 1982.
46. PSL Wong, BL Barclay, JC Deters, F Theeuwes. Osmotic device for administering certain drugs. US Patent 4,765,989, 1988.
47. D Swanson, B Barclay, P Wong, F Theeuwes. Nifedipine gastrointestinal system. Am J Med 83(Suppl 6B):3-9, 1987.
48. AD Ayer, DR Swanson, AL Kuczynski. Dosage form for treating cardiovascular diseases. US Patent 4,950,486, 1990.
49. JC Deters, PSL Wong, BL Barclay, F Theeuwes, DR Swanson. Dosage form for dispensing drug for human therapy. US Patent 4,837,111, 1989.
50. GV Guittard, PSL Wong, F Theeuwes, R Cortese. Dosage form for delivering diltiazem. US Patent 4,859,470, 1989.
51. J Wright, JD Childers, BL Barclay, PSL Wong, LE Atkinson. Osmotic dosage form comprising an estrogen and a progestogen. US Patent 4,948,593, 1990.
52. AL Kuczynski, AD Ayer, PSL Wong. Oral hypoglycemic glipizide granulation. US Patent 5,024,843, 1991.
53. F Jao, PS Wong, HT Huynh, K McCheeney, PK Wat. Verapamil therapy. US Patent 5,160,744, 1992.
54. AD Ayer, LG Lawrence. Pseudoephedrine brompheniramine therapy. US Patent 4,810,502, 1989.
55. PSL wong, F Theeuwes, BL Bailey, MH Desley. Osmotic dosage system for delivering a formulation comprising liquid carrier and drug. US Patent 5,324,280, 1995.
56. PSL Wong, F Theeuwes, BL Bailey, MH Desley. Osmotic dosage form for liquid delivery. US Patent 5,413,572, 1995.
57. DG Pope, PK Wilkinson, JR Egerton, J Conroy. Oral controlled release delivery of ivermectin in cattle via an osmotic pump. J Pharm Sci 74:1108-1110, 1985.
58. JR Egerton, D Suhayda, CH Eary. Prophylaxis of nematode infections in cattle with an indwelling, ruminoreticular ivermectin sustained release bolus. Vet Parasitol 74: 614-617, 1986.
59. B Eckenhoff, R Cortese, JC Wright, PK Wilkinson, JR Zingerman, DG Pope. Osmotically-driven ruminal delivery system for the long term rate controlled delivery of ivermectin. Pharm Res (Suppl)4:46, 1987.
60. B Eckenhoff, R Cortese, FA Landrau. Delivery system for controlled administration to ruminants, US Patent 4,595,583, 1986.
61. JL Zingerman, JR Cardinal, RT Chern, J Holste, JB Williams, B Eckenhoff, JT Wright. The in vitro and in vivo performance of an osmotically controlled delivery system-IVOMEC SR Bolus?. J Controlled Release 47:1-11, 1997.
62. JR Cardinal. Intraruminal boluses. Adv Drug Deliv Rev 28:303-322 (1997).
63. JB Eckenhoff, R Cortese, FA Landrau. Dispenser for delivering drug to livestock. US Patent 4,927,633, 1990.
64. AD Ayer, F Theeuwes, PS Wong. Pulsed drug delivery of doxylamine. US Patent 4,842,867, 1989.
65. AD Ayer, F Theeuwes, PS Wong. Pulsed drug delivery. US Patent 4,848,592, 1990.
66. GL Amidon, GD Leesman, LB Sherman. Multi stage delivery system. US Patent 5,387,421, 1995.